arrow
H

Henkjan J. Verkade

University of Groningen
H指数:58
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Maternal influences on infant gut microbiome and health

母体对婴儿肠道微生物群与健康的影响

Nature
IF48.5
2026-08-120
OAAI
Mice with humanized FXR ligand-binding domain display distinct metabolic responses upon pharmacological FXR stimulation

人源化FXR配体结合域的小鼠在药理FXR刺激下表现出不同的代谢反应

2026-06-250
OAAI
Elevated Serum Bile Acids Predict Poor Liver Outcomes in Children With Alagille Syndrome: Results From the GALA Study Group

血清胆汁酸升高可预测Alagille综合征患儿的肝脏不良结局:GALA研究小组的结果

2025-11-180
OAAI
Generation and characterization of a mouse model for bile salt export pump deficiency with the p.E297G mutation

生成和表征具有p.E297G突变的胆盐外排泵缺陷小鼠模型

2025-10-170
PRE
Odevixibat after liver transplant in patients with progressive familial intrahepatic cholestasis type 1: A case series

奥贝胆酸在肝移植后患有进行性家族性肝内胆汁淤积症1型的患者中的应用:一个病例系列

2025-10-010
OAAI
Erratum to ‘Inhibition of ATGL alleviates MASH via impaired PPARa signalling that favours hydrophilic bile acid composition in mice’ [J Hepatol 82 (2025) 658–675]

勘误:‘Inhibition of ATGL alleviates MASH via impaired PPARa signalling that favours hydrophilic bile acid composition in mice’ [J Hepatol 82 (2025) 658–675]

2025-08-300
OAAI
Phenotypic Divergence of JAG1- and NOTCH2-Associated Alagille Syndrome & Disease-Specific NOTCH2 Variant Classification Guidelines

JAG1和NOTCH2相关Alagille综合征的表型分歧与疾病特异性NOTCH2变异分类指南

2025-07-310
OAAI
Genome-wide meta-analysis associates donor-recipient non-HLA genetic mismatch with acute cellular rejection post-liver transplantation
2025-01-010
OAAI
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind randomised, placebo-controlled trial
2024-07-015
OAAI